Thyroid disorder — all decisions

The appeal for an earlier effective date for the award of a 30 percent evaluation for hypothyroidism to include adjustment disorder with mixed anxiety and depression was dismissed as the Veteran withdrew his appeal.

The Board granted service connection for a thyroid disorder and denied service connection for a gastrointestinal (GI) disorder.

The Board granted readjudication of the claims for service connection for hypothyroidism, hypertension, allergic rhinitis, and an acquired psychiatric disorder based on new and relevant evidence.

The Board granted service connection for cancer of the larynx, status post laryngectomy, and hypothyroidism, to include as secondary to a service-connected disability.

The Board denied a rating in excess of 30 percent for bilateral hearing loss and remanded the claims for service connection for obstructive sleep apnea, a compensable rating for hypothyroidism, and entitlement to a total rating based on individual unemployability.

The Board denied service connection for diabetes mellitus Type II, left lower extremity peripheral neuropathy, right lower extremity peripheral neuropathy, and thyroid cancer as there was no evidence of in-service incurrence or a causal relationship between the claimed conditions and the Veteran's military service.

The Board granted service connection for bilateral hearing loss disability but denied service connection for asbestosis and hypothyroidism.

The Board remands the case to correct pre-decisional duty to assist errors, including obtaining private treatment and Social Security Administration records.

The Board remands the claim for a thyroid condition to be re-evaluated with an adequate medical opinion, as the previous VA examination was found inadequate.

The Board granted service connection for hypothyroidism on a direct basis, finding that the evidence is at least evenly balanced as to whether the Veteran's condition is related to in-service herbicide agent exposure.

The Board denied the claims for earlier effective dates, increased ratings, and service connection due to insufficient evidence linking the conditions to active service or other presumptive exposures.

The Board denied the Veteran's claims for an initial compensable rating for hypothyroidism and an increased rating in excess of 30 percent for xerosis/asteatosis.

The Board denied service connection for GERD, insomnia, and thyroid nodular disease as there was no evidence of an in-service onset or continuity of symptomology since separation. The claim for hypertension is remanded for a direct service connection medical opinion.

The Board remands the claims for service connection for chronic kidney disease, CML, hypertension, non-allergic rhinitis, and hypothyroidism to obtain a VA examination that addresses the Veteran's competent and credible statements of exposure to fumes as causing his conditions.

The Board denied service connection for hypothyroidism, insomnia, and a lower back disability as the evidence did not support the presence of these conditions during or after active service. The claims for sinusitis and GERD were remanded for further development.

The Board denied an increased evaluation for hypertension and remanded the claims for service connection for hypothyroidism and an increased evaluation for a right wrist sprain with De Quervain's syndrome.

The Board granted service connection for hypothyroidism with Hashimoto's disease and an adjustment disorder with mixed depression and anxiety as secondary to the service-connected condition.

The Board granted service connection for a parathyroid disability, kidney disability, and psychiatric disorder based on evidence of in-service toxic exposure risk activity (TERA).

The Board remands the claims for an increased rating for hypothyroidism and entitlement to TDIU due to inadequate examination reports.

The Board granted service connection for hypertension, pancreatitis, and benign neoplasm of the thyroid but denied a compensable rating for benign bladder mass and an increased rating for tinnitus. The effective date for both conditions was set to August 10, 2022.